YJC-10592
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
YJC-10592, a novel chemokine receptor 2 (CCR-2) antagonist, was developed for treating asthma and atopic dermatitis. We studied…
YJC-10592, a new chemokine receptor 2 (CCR-2) antagonist, was newly synthesized for the treatment of asthma and atopic dermatitis…